Maintenance Dose for Digoxin in AF with RVR
For an adult with atrial fibrillation with rapid ventricular response and normal renal function, the standard maintenance dose of digoxin is 0.25 mg once daily, though 0.125 mg daily is appropriate for most patients, particularly those over 70 years of age. 1, 2
Dosing Algorithm
Standard Adult Dosing (Normal Renal Function)
Initial maintenance dose selection:
- Age <70 years with good renal function: 0.25 mg once daily 2
- Age ≥70 years: 0.125 mg once daily 1, 2
- Marked renal impairment: 0.0625 mg once daily 2
Key Considerations for AF with RVR
The ESC guidelines specifically address digoxin use in AF with rapid ventricular response, stating that digoxin is useful for initial control of ventricular rate in patients with rapid AF (Class I recommendation, Level of Evidence C) 1. However, the guidelines emphasize that beta-blockers, either alone or in combination with digoxin, are the preferred long-term treatment for rate control 1.
Important Dosing Nuances
Loading doses are generally NOT required in stable patients with chronic AF 1, 2. The FDA label states that "loading doses of digoxin are generally not required in stable patients with sinus rhythm," and this applies to chronic AF management as well 2. Steady-state concentrations will be achieved in approximately 5 half-lives (1-3 weeks depending on renal function) 2.
Target serum concentration: The therapeutic range has been revised downward from historical recommendations. The target serum digoxin concentration should be 0.6-1.2 ng/mL 1, which is lower than previously recommended. This is particularly important as higher concentrations (>1.2 ng/mL) have been associated with increased mortality 3.
Dose Adjustments Based on Clinical Factors
Renal function is the primary determinant of maintenance dosing. The FDA provides a detailed table based on creatinine clearance and lean body weight 2:
- CrCl ≥60 mL/min: 0.25 mg daily (for 70 kg patient)
- CrCl 40-60 mL/min: 0.1875-0.25 mg daily
- CrCl 20-40 mL/min: 0.125-0.1875 mg daily
- CrCl <20 mL/min: 0.0625-0.125 mg daily
Recent research supports that 0.125 mg daily is appropriate for most Japanese patients with AF and heart failure, with dose reduction to 0.0625 mg for those with CrCl <30 mL/min 4.
Critical Pitfalls to Avoid
Do NOT use high doses (>0.25 mg daily) for rate control in AF. The consensus guidelines explicitly state that "the administration of high doses of digoxin (>0.25 mg daily) for the purpose of rate control is not recommended" 3. If additional rate control is needed, add a beta-blocker or amiodarone rather than increasing digoxin dose.
Drug interactions significantly affect digoxin levels. Amiodarone, diltiazem, verapamil, certain antibiotics, and quinidine can increase plasma digoxin levels 1. When amiodarone is added, reduce the digoxin dose 3. Recent pharmacokinetic analysis confirms that concurrent amiodarone use requires dose reduction to 0.0625 mg daily to avoid toxicity 4.
Monitor for toxicity, especially with hypokalemia. Serial monitoring of serum electrolytes and renal function is mandatory 1. Digoxin toxicity commonly occurs with levels >2 ng/mL but can occur at lower levels with hypokalemia, hypomagnesemia, or hypothyroidism 3.
Monitoring Strategy
Routine serum digoxin level monitoring is NOT necessary in most stable patients 1. The radioimmunoassay was developed to evaluate toxicity, not efficacy, and there is little relationship between serum concentration and therapeutic effects in the absence of toxicity 3. However, check levels early during therapy if there are concerns about toxicity or inadequate response 1.
Clinical response should guide therapy, not arbitrary serum levels. The goal is adequate ventricular rate control (resting heart rate <80-110 bpm) without adverse effects 1.